Florian Malchers

1.5k total citations
8 papers, 300 citations indexed

About

Florian Malchers is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Florian Malchers has authored 8 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Florian Malchers's work include Fibroblast Growth Factor Research (6 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Florian Malchers is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Florian Malchers collaborates with scholars based in Germany, United States and Belgium. Florian Malchers's co-authors include Roman K. Thomas, Martin L. Sos, Martin Peifer, Lydia Meder, Johannes M. Heuckmann, Mirjam Koker, Lukas C. Heukamp, Ralf Küppers, William Pao and Christine M. Lovly and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Florian Malchers

7 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Malchers Germany 4 220 191 151 79 44 8 300
Andrea E. Doak United States 6 253 1.1× 200 1.0× 161 1.1× 128 1.6× 41 0.9× 7 350
Santosh Gupta United States 6 163 0.7× 122 0.6× 73 0.5× 106 1.3× 30 0.7× 15 246
Igor Odintsov United States 9 146 0.7× 123 0.6× 94 0.6× 52 0.7× 27 0.6× 24 235
S. Gadgeel United States 5 153 0.7× 129 0.7× 133 0.9× 67 0.8× 25 0.6× 16 262
Christina J. Falcon United States 11 215 1.0× 183 1.0× 98 0.6× 64 0.8× 23 0.5× 22 304
Amaya Gascó Spain 7 164 0.7× 159 0.8× 98 0.6× 95 1.2× 25 0.6× 18 248
Margherita Carucci United Kingdom 5 195 0.9× 165 0.9× 133 0.9× 93 1.2× 19 0.4× 7 301
Giovanni Burrafato Italy 9 139 0.6× 157 0.8× 64 0.4× 96 1.2× 35 0.8× 13 247
Maria Giuseppa Sarobba Italy 10 102 0.5× 194 1.0× 137 0.9× 147 1.9× 26 0.6× 18 344
Scott Barker United States 6 175 0.8× 155 0.8× 57 0.4× 72 0.9× 23 0.5× 19 259

Countries citing papers authored by Florian Malchers

Since Specialization
Citations

This map shows the geographic impact of Florian Malchers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Malchers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Malchers more than expected).

Fields of papers citing papers by Florian Malchers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Malchers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Malchers. The network helps show where Florian Malchers may publish in the future.

Co-authorship network of co-authors of Florian Malchers

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Malchers. A scholar is included among the top collaborators of Florian Malchers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Malchers. Florian Malchers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nogová, Lucia, Florian Malchers, Axel M. Hillmer, et al.. (2023). 1329P FIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered NSCLC. Annals of Oncology. 34. S767–S767. 2 indexed citations
2.
Siemanowski, Janna, Florian Malchers, Matthias Scheffler, et al.. (2023). Clinical characteristics and treatment outcome of patients with advanced non-small-cell lung cancer (NSCLC) and FGFR fusions.. Journal of Clinical Oncology. 41(16_suppl). e21139–e21139. 1 indexed citations
3.
Malchers, Florian, Axel M. Hillmer, Sabine Merkelbach‐Bruse, et al.. (2022). Screening of FGFR patients for FGFR directed clinical trials in Network Genomic Medicine (NGM): Real-world data.. Journal of Clinical Oncology. 40(16_suppl). e21013–e21013.
4.
Meder, Lydia, Mirjam Koker, Sven Borchmann, et al.. (2018). Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene. 37(42). 5682–5693. 31 indexed citations
5.
Nogová, Lucia, Florian Malchers, Axel M. Hillmer, et al.. (2018). P1.01-72 FIND Trial: A Phase II Study to Evaluate the Efficacy of the FGFR-Inhibitor Erdafitinib in FGFR-Mutated and -Translocated Squamous NSCLC. Journal of Thoracic Oncology. 13(10). S490–S490. 1 indexed citations
6.
Malchers, Florian, Meryem S. Ercanoglu, Roberta Castiglione, et al.. (2017). Mechanisms of Primary Drug Resistance in FGFR1 -Amplified Lung Cancer. Clinical Cancer Research. 23(18). 5527–5536. 41 indexed citations
8.
Heuckmann, Johannes M., Hyatt Balke‐Want, Florian Malchers, et al.. (2012). Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants. Clinical Cancer Research. 18(17). 4682–4690. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026